5′-Methylthioadenosine Modulates the Inflammatory Response to Endotoxin in Mice and in Rat Hepatocytes

Hepatology

Volumn 39, Issue 4, 2004, Pages 1088-1098

  Hevia, Henar ^a   Varela Rey, Marta ^a   Corrales, Fernando J ^a   Berasain, Carmen ^a   Martínez Chantar, María L ^a   Latasa, M Ujue ^a   Lu, Shelly C ^b   Mato, José M ^a,c   García Trevijano, Elena R ^a,d   Avila, Matías A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HMR 415 ^*  (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5' METHYLTHIOADENOSINE; BACTERIUM LIPOPOLYSACCHARIDE; CYCLOOXYGENASE 2 INHIBITOR; ENDOTOXIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN; S ADENOSYLMETHIONINE; TUMOR NECROSIS FACTOR ALPHA; 5'-METHYLTHIOADENOSINE; ANTIINFLAMMATORY AGENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEOXYADENOSINE DERIVATIVE; ENZYME INHIBITOR; LIPOPOLYSACCHARIDE; NUCLEOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVATION; IMMUNOMODULATION; INFLAMMATION; LIVER CELL CULTURE; LIVER INJURY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECT; HUMAN; IMMUNOLOGY; KUPFFER CELL; LIVER CELL; METABOLISM; RAT; SEPTIC SHOCK; TUMOR CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE, TUMOR; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEOXYADENOSINES; ENZYME INHIBITORS; HEPATOCYTES; HUMANS; KUPFFER CELLS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; RATS; S-ADENOSYLMETHIONINE; SHOCK, SEPTIC; THIONUCLEOSIDES;

EID: 1842479963     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20154     Document Type: Article

References (50)

1. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002;71:635-700.
2. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leuk Biol 1993;54:171-178.
3. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 2002;283: G256-G265.
4. Tracey KJ, Cerami A. Tumor necrosis factor a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994;45:491-503.
5. Li J, Billiar TR. Nitric oxide IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol Gastrointest Liver Physiol 1999;276: G1069-G1073.
6. Curran RD, Billiar TR, Stuehr DJ, Ochoa JB, Harbretch BG, Flint SG, Simmons RL. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 1990;212: 462-469.
7. Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995;108:1835-1841.
8. Avila MA, García-Trevijan ER, Martínez-Chantar ML, Latasa MU, Pérez-Mato I, Martínez-Cruz LA, Sánchez del Pino MM, et al. S-adenosylmethionine revisited: its essential role in the regulation of liver function. Alcohol 2002;27:163-167.
9. Mato JM, Cámara J, Fernández de Paz J, Caballería J, Coll S, Caballero A, García-Buey L, et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double blind, multicenter clinical trial. J Hepatol 1999;30:1081-1089.
10. McClain CJ, Hill DB, Song Z, Chawla RJ, Watson WH, Chen T, Barve S. S-adenosylmethionine, cytokines, and alcoholic liver disease. Alcohol 2002;27:185-192.
11. Corrales FJ, Giménez A, Alvarez L, Caballería J, Pajares MA, Andreu H, Parés A, et al. S-adenosylmethionine treatment prevents CC14-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. HEPATOLOGY 1992;16:1022-1027.
12. Bray GP, Tredger JM, Williams R. S-adenosylmethionine protects against acetaminophen hepatotoxicity in two mouse models. HEPATOLOGY 1992; 15:297-301.
13. Lieber CS, Casini A, De Carli LM, Kim C, Lowe N, Sasaki R, Leo MA. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. HEPATOLOGY 1990;11:165-172.
14. García-Ruiz C, Morales A, Collel A, Ballesta A, Rodés J, Kaplowitz N, Fernández-Checa JC. Feeding S-adenosyl-L-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes. HEPATOLOGY 1995;21:207-214.
15. Chawla RK, Watson WH, Eastin CE, Lee EY, Schmidt J, McClain CJ. S-adenosylmethionine deficiency and TNF-α in lipopolysaccharide-induced hepatic injury. Am J Physiol Gastrointest Liver Physiol 1998;275: G125-G129.
16. Watson WH, Zhao Y, Chawla RK. S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumor necrosis factor-α. Biochem J 1999;342:21-25.
17. Majano PL, García-Monzón C, García-Trevijano ER, Corrales FJ, Cámara J, Ortiz P, Mato JM, et al. S-adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes. J Hepatol 2001;35:692-699.
18. Song Z, Barv S, Chen T, Nelson W, Uriarte S, Hill D, McClain C. S-adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes. Am J Physiol Gastrointest Liver Physiol 2003;284:G949-G955.
19. Mato JM, Corrales FJ, Lu SC, Avila MA. S-adenosylmethionine: a control switch that regulates liver function. FASEB J 2002;16:15-26.
20. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990;1:228-236.
21. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 1988;15:759-774.
22. Wu SE, Huskey WP, Borchardt RT, Schowen REL. Chiral instability at sulfur of S-adenosylmethionine. Biochemistry 1983;22:2828-2832.
23. Latasa MU, Boukaba A, García-Trevijano ER, Torres L, Rodriguez JL, Caballería J, Lu SC, et al. Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes. Role in liver regeneration. FASEB J 2001;15:1248-1250.
24. Pascale RM, Simile MM, Satta G, Seddaiu MA, Daino L, Pinna G, Vinci MA, et al. Comparative effects of L-methionine, S-adenosyl-L-methionine and 5′-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis. Anticancer Res 1991;11:1617-1624.
25. Ansorena E, García-Trevijano ER, Martínez-Chantar ML, Huang ZZ, Chen L, Mato JM, Iraburu M, et al. S-adenosylmethionine and methylthioadenosine are anti-apoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. HEPATOLOGY 2002;35:274-280.
26. Simile MM, Banni S, Angioni E, Carta G, De Miglio MR, Muroni MR, Calvisi DF, et al. 5′-methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon-tetrachloride intoxication. J Hepatol 2001;34:386-394.
27. Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF, Gores GJ. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. HEPATOLOGY 2003;38:1188-1198.
28. Marks-Konczalik J, Chu SC, Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor-kappa B-binding sites. J Biol Chem 1998;273:22201-22208.
29. Titheradge MA. Nitric oxide in septic shock. Biochim Biophys Acta 1999; 1411:437-455.
30. Vane JR, Blake YS, Botting RM. Cyclooxygenase 1 and 2. Annu Rev Pharmacol and Toxicol 1998;38:97-120.
31. Waldleigh DJ, Reddy ST, Kopp E, Ghosh S, Herschman HR. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem 2000;275:6259-6266.
32. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994;18:4705-4708.
33. Salituro FG, Germann UA, Wilson KP, Bemis GW, Fox T, Su MS. Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases. Curr Med Chem 1999;6:807-823.
34. Martínez-Chantar ML, Latasa MU, Varela-Rey M, Lu SC, García-Trevijano ER, Mato JM, Avila MA. L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells. J Biol Chem 2003;278:19885-19890.
35. Nobori T, Szinai I, Amox D, Parker B, Olopade OI, Bucchagen DL, Carson DA. Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers. Cancer Res 1993;53:1098-1101.
36. Munshi R, Clanachan AS, Baer HP. 5′-deoxy-5′ -methylthioadenosine: a nucleoside which differentiates between adenosine receptor types. Biochem Pharmacol 1988;37:2085-2089.
37. 2A adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem Pharmacol 2003;65:493-501.
38. Meng X, Ao L, Shames BD, Harken AH. Inhibition of cyclic-3′ ,5′-nucleotide phosphodiesterase abrogates the synergism of hypoxia with lipopolysaccharide in the induction of macrophage TNF-alpha production. J Surg Res 2001;101:210-215.
39. Wang S, Yan L, Wesley R, Danner RL. Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP. J Biol Chem 1997;272:5959-5965.
40. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 19:641-650.
41. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, et al. Anti-catechin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987;330:662-664.
42. Howard M, Muchamuel S, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177:4244-4249.
43. Haskó G, Szabó C, Németh ZH, Kvetan V, McCarthy Pastores S, Vizi ES. Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 1996;157:4634-4640.
44. Riscoe MK, Tower PA, Ferro AJ. Mechanism of action of 5′-methylthioadenosine in S49 cells. Biochem Pharmacol 1984;33:3639-3643.
45. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, Firestein GS. Inhibition of TNF-α expression by adenosine. Role of A3 adenosine receptors. J Immunol 1996;156:3435-3442.
46. Böhrer H, Qiu F, Zimmermann T, Zhang Y, Jilmer T, Männel D, Böttiger BW, et al. Role of NFKB in the mortality of sepsis. J Clin Invest 1997;100:972-985.
47. Law RE, Stimmel JB, Damore MA, Carter S, Clarke S, Wall R. Lipopolysaccharide-induced NF-KB activation in mouse 70Z/3 pre-B lymphocytes is inhibited by mevinolin and 5′-methylthioadenosine: roles of protein isoprenylation and carboxyl methylation reactions. Mol Cell Biol 1992;12:103-111.
48. Smith DS, King CS, Pearson E, Gittinger CK, Landreth GE. Selective inhibition of nerve growth factor-stimulated protein kinases by K-252a and 5′-S-methylthioadenosine in PC12 cells. J Neurochem 1989;53:800-806.
49. Li H, Park S, Kilburn B, Jelinek MA, Henschen-Edman A, Aswad DW, Stallcup MR, et al. Lipopolysaccharide-induced methylation of HuR, an mRNA stabilizing protein, by CARM1. J Biol Chem 2002;277:44623-44630.
50. Mowen KA, Tang J, Zhu W, Schurter BT, Shuai K, Herschman HR, David M. Arginine methylation of STAT1 modulates IFNα/β-induced transcription. Cell 2001;104:731-741.